110 related articles for article (PubMed ID: 38821605)
1. Significance of MUC1 and β-Catenin Localization in Mucinous Carcinoma of the Breast.
Sugawara-Komatsu K; Fujii T; Kurozumi S; Ishikawa H; Katayama A; Handa T; Tougou M; Sano T; Matsumoto H; Kurosumi M; Horiguchi J; Shirabe K; Oyama T
Anticancer Res; 2024 Jun; 44(6):2689-2698. PubMed ID: 38821605
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
Lei L; Yu X; Chen B; Chen Z; Wang X
PLoS One; 2016; 11(5):e0155132. PubMed ID: 27232881
[TBL] [Abstract][Full Text] [Related]
3. Do clinical and immunohistochemical findings of pure mucinous breast carcinoma differ from mixed mucinous breast carcinoma?
Erhan Y; Ciris M; Zekioglu O; Erhan Y; Kapkac M; Makay O; Ozdemir N
Acta Chir Belg; 2009; 109(2):204-8. PubMed ID: 19499682
[TBL] [Abstract][Full Text] [Related]
4. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
[TBL] [Abstract][Full Text] [Related]
5. [Neuroendocrine differentiation and Wilms' tumor protein-1 expression in breast mucinous carcinoma and their significance].
Wang J; Weng S; Jin X; Yu W; Zhou T; Gan M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):45-50. PubMed ID: 27045240
[TBL] [Abstract][Full Text] [Related]
6. CDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast.
García-Labastida L; Garza-Guajardo R; Barboza-Quintana O; Rodríguez-Sanchez IP; Ancer-Rodríguez J; Flores-Gutierrez JP; Gómez-Macías GS
Biol Res; 2014 Sep; 47(1):43. PubMed ID: 25299496
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic features of micropapillary variant of pure mucinous carcinoma of breast].
Lin HY; Gao LX; Jin ML; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):613-7. PubMed ID: 23157830
[TBL] [Abstract][Full Text] [Related]
8. Mucinous micropapillary carcinoma of the breast: an aggressive counterpart to conventional pure mucinous tumors.
Barbashina V; Corben AD; Akram M; Vallejo C; Tan LK
Hum Pathol; 2013 Aug; 44(8):1577-85. PubMed ID: 23517923
[TBL] [Abstract][Full Text] [Related]
9. Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.
Kim D; Jung WH; Koo JS
Pathobiology; 2012; 79(3):144-53. PubMed ID: 22269464
[TBL] [Abstract][Full Text] [Related]
10. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters.
Tse GM; Ma TK; Chu WC; Lam WW; Poon CS; Chan WC
Mod Pathol; 2004 May; 17(5):568-72. PubMed ID: 15001999
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).
Buyuk M; Ozluk Y; Bakkaloglu DV; Ozkan B; Firat P; Yilmazbayhan D
Turk Patoloji Derg; 2023; 39(1):64-74. PubMed ID: 36367122
[TBL] [Abstract][Full Text] [Related]
13. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
[TBL] [Abstract][Full Text] [Related]
14. Micropapillary pattern in pure mucinous carcinoma of the breast - does it matter or not?
Xu X; Bi R; Shui R; Yu B; Cheng Y; Tu X; Yang W
Histopathology; 2019 Jan; 74(2):248-255. PubMed ID: 30066338
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Study of Mucinous Carcinoma of Breast with Emphasis on Cytological Features: A Study at Tertiary Care Teaching Hospital of South India.
Chikkannaiah P; Thangngeo D; Guruprasad C; Venkataramanappa S
J Lab Physicians; 2020 Mar; 12(1):68-75. PubMed ID: 32792796
[No Abstract] [Full Text] [Related]
16. Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.
Togami S; Nomoto M; Higashi M; Goto M; Yonezawa S; Tsuji T; Batra SK; Douchi T
J Obstet Gynaecol Res; 2010 Jun; 36(3):588-97. PubMed ID: 20598042
[TBL] [Abstract][Full Text] [Related]
17. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis.
O'Connell JT; Shao ZM; Drori E; Basbaum CB; Barsky SH
Hum Pathol; 1998 Dec; 29(12):1517-23. PubMed ID: 9865841
[TBL] [Abstract][Full Text] [Related]
18. Micropapillary variant of mucinous breast carcinoma: A distinct subtype.
Collins K; Ricci A
Breast J; 2018 May; 24(3):339-342. PubMed ID: 29063656
[TBL] [Abstract][Full Text] [Related]
19. Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long-term follow-up.
Toikkanen S; Kujari H
Hum Pathol; 1989 Aug; 20(8):758-64. PubMed ID: 2545592
[TBL] [Abstract][Full Text] [Related]
20. Pure Mucinous Carcinoma of the Breast: Radiologic-Pathologic Correlation.
Kuzmiak CM; Calhoun BC
J Breast Imaging; 2023 Mar; 5(2):180-187. PubMed ID: 38416927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
